As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

We recently published a list of Top 10 Stocks Everyone is Talking About. In this article, we are going to take a look at ...

Canadian investors could consider owning beaten-down AI stocks such as AMD to generate outsized gains in the next 12 months.

UiPath, a leading enterprise automation and AI software company, has announced its annual UiPath Agentic AI Summit will take ...

UiPath to hold Agentic AI Summit on March 25 to demonstrate its latest agentic automation innovations and how UiPath ...

In the biotech sphere, ARK ETFs continued to accumulate shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Intellia Therapeutics Inc (NASDAQ: NTLA ), with purchases of 67,787 and 194,844 shares, ...

Zurcher Kantonalbank Zurich Cantonalbank grew its stake in UiPath Inc. (NYSE:PATH – Free Report) by 57.5% in the 4th quarter, ...

Steward Partners Investment Advisory LLC grew its position in shares of UiPath Inc. (NYSE:PATH – Free Report) by 99.8% during ...

AI-powered robotics are set to soar in 2025. Key players like NVDA, ISRG, TSLA and PATH lead transformation across healthcare, manufacturing and mobility sectors.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

UiPath (PATH) has seen its stock hit an all-time low following a bleak revenue forecast issued as a part of its Q4 FY 2025 financial results.

BMO Capital analyst Keith Bachman lowered the firm’s price target on UiPath (PATH) to $11.50 from $16 and keeps a Market Perform rating on the ...